SELL Divi's Laboratories Limited — Prabhudas Lilladher
byPrabhudas LilladherHorizon: NA (inferred 1 year)11 Feb 2024via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.
2 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·10 Nov · 3mo ago
Nothing found in this tip’s window yet.
1 other SEBI-registered advisor has an active long-term BUY call on this stock
Advisor consensus · same horizon·11 Nov · 3mo ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Divi's Laboratories
- BUY — Ashish Bahety, Profitmart Securities22 Oct 2026 · Same day · target ₹9,350 · SL hit
- SELL — Prakash Gaba14 Oct 2026 · ~2 weeks · target ₹8,750 · SL hit
- SELL — Mehul Kothari, Anand Rathi14 Oct 2026 · ~2 weeks · target ₹8,400 · Active
- BUY — Kavita Jain, Arihant Capital Markets6 Oct 2026 · Next day · target ₹9,750 · Expired
- BUY — Chandan Taparia, Motilal Oswal24 Sept 2026 · ~2 weeks · target ₹10,000 · SL hit
More from Prabhudas Lilladher
- BUY Sai Life Sciences21 Oct 2026 · ~1 year · target ₹1,620 · Active
- BUY Union Bank of India20 Oct 2026 · ~1 year · target ₹200 · Active
- BUY Nestle India15 Oct 2026 · ~1 year · target ₹1,526 · Active
- BUY Tata Elxsi14 Oct 2026 · ~1 year · target ₹3,790 · Target hit
- SELL Avenue Supermarts12 Oct 2026 · ~3 months · target ₹3,214 · Target hit

